Microdialysis studies with 5-HT reuptake inhibitors

Persistence of long-lasting serotonin depletion by p-chloroamphetamine in rat brain after 6-hydroxydopamine lesioning of dopamine neurons.

Biochemical pharmacology·1995

Assessing equivalence of inhaled drugs.

Respiratory medicine·1995

Postoperative radiation therapy in clinical stage I endometrial cancer: corpus, cervical, and lower uterine segment involvement--patterns of failure.

Radiology·1995

The effect of topical fluticasone propionate on intranasal histamine challenge in subjects with perennial allergic rhinitis.

Clinical otolaryngology and allied sciences·1995

Loss of response to beta-adrenoceptor agonists during the maturation of human monocytes to macrophages in vitro.

Journal of leukocyte biology·1995

Decreased hypothalamic epinephrine concentration by quipazine and other serotonin agonists in rats.

Biochemical pharmacology·1995

Lysosome-targeted protein degradation platforms for spatiotemporally controlled degradation.

Trends in pharmacological sciences·2026

Sex-sensitive serotonergic signaling in psychedelic pharmacology.

Trends in pharmacological sciences·2026

Amyloidogenic amylin signaling links diabetes to dementia pathogenesis.

Trends in pharmacological sciences·2026

STAT3 signaling inhibitors for cancer treatment.

Trends in pharmacological sciences·2026

STING-mediated cancer immunotherapy: emerging modalities and beyond.

Trends in pharmacological sciences·2026

Forever chemicals, the microbiome, and brain health: towards therapeutics.

Trends in pharmacological sciences·2026

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Cureus·2026

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Frontiers in endocrinology·2026

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Canadian journal of kidney health and disease·2026

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Frontiers in pharmacology·2026

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Frontiers in molecular neuroscience·2026

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Therapeutic advances in neurological disorders·2026

Related Experiment Videos

Microdialysis studies with 5-HT reuptake inhibitors

Related Concept Videos

Persistence of long-lasting serotonin depletion by p-chloroamphetamine in rat brain after 6-hydroxydopamine lesioning of dopamine neurons.

Assessing equivalence of inhaled drugs.

Postoperative radiation therapy in clinical stage I endometrial cancer: corpus, cervical, and lower uterine segment involvement--patterns of failure.

The effect of topical fluticasone propionate on intranasal histamine challenge in subjects with perennial allergic rhinitis.

Loss of response to beta-adrenoceptor agonists during the maturation of human monocytes to macrophages in vitro.

Decreased hypothalamic epinephrine concentration by quipazine and other serotonin agonists in rats.

Lysosome-targeted protein degradation platforms for spatiotemporally controlled degradation.

Sex-sensitive serotonergic signaling in psychedelic pharmacology.

Amyloidogenic amylin signaling links diabetes to dementia pathogenesis.

STAT3 signaling inhibitors for cancer treatment.

STING-mediated cancer immunotherapy: emerging modalities and beyond.

Forever chemicals, the microbiome, and brain health: towards therapeutics.

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Related Experiment Videos

Microdialysis studies with 5-HT reuptake inhibitors

Related Concept Videos

Related Articles